A kininogenase resembling glandular kallikrein was partially purified from vascular tissue and characterized. Saline-perfused rat tail arteries and veins were homogenized in 0.25 M sucrose containing 10 ITIM Tris-HCl (pH 7.4). The homogenate was centrifuged at 105,000 g for 60 minutes, and a vascular kininogenase was purified from the supernatant by chromatofocusing, affinity chromatography on immobilized antibodies against rat urinary kallikrein, and gel filtration on Sephadex G-100. The inhibitory effects of antibodies against rat urinary kallikrein were tested with equivalent kinin-forming concentrations of rat urinary kallikrein and vascular kininogenase. Kininogenase activities of both enzymes were similarly inhibited by both polydonal and monoclonal antibodies. Aprotinin (1,000 JQU) completely inhibited vascular kininogenase activity, while soybean trypsin inhibitor (100 /ig) did not modify its kinin-forming activity. Vascular kininogenase and rat urinary kallikrein had the same elution volume when chromatographed on a Sephadex G-100 column, and had similar mobilities in 10% polyacrylamide gel electrophoresis. Kinins released by vascular kininogenase were identified as bradykinin by reverse-phase high performance liquid chromatography. Rat vascular kininogenase appears to be similar to glandular kallikrein. Kinins released locally by vascular kininogenase may contribute to the regulation of vascular tone. {Circ Res 56: [816][817][818][819][820][821] 1985) 
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Methods

Reagents
The following materials were obtained from commercial sources: molecular weight markers, polybuffer anion exchanger (PBE 94), and polybuffer 74 (Pharmacia Fine Chemicals); captopril (Squibb); polyacrylamide (Eastman Kodak); all other reagents used were analytical grade.
Aprotinin was a kind gift from G. Haberland, (A.G. Bayer, W. Germany).
Preparation of Tissue Extracts
One hundred male and female Sprague-Dawley rats (400-500 g) were used. After an animal was killed by decapitation, the ventral artery and veins of the tail were exposed proximally through small incisions and catheterized with P.E. 50 polyethylene tubing (Friedman et al., 1968) . The tail was perfused through the artery with a buffered saline solution (pH 7.4) for 10-20 minutes at a flow rate of 1.0 ml/min until the effluent collected from the veins appeared visually free of blood. Subsequently, the vessels were removed, cleaned of any adherent fat and connective tissue, and placed in Petri dishes containing a saline solution. The tail vascular bed was washed by renewing the saline solution several times. Then, the vessels were cut into 1-2 mm rings and kept frozen at -70°C.
For the experiments, 600 mg of tail arteries, 800 mg of tail veins, or 4,200 mg of pooled tail vessels were used. The vessels were frozen and thawed four times. The tissue was suspended in three volumes of 0.25 M sucrose (pH 7.0) and homogenized on ice for four 15-second intervals with a Polytron homogenizer. The homogenate was centrifuged at 1,000 g for 10 minutes to eliminate debris. The supernatant was further centrifuged at 105,000 g for 60 minutes in a L-5 Beckman ultracentrifuge. This supernatant was dialyzed overnight at 4°C against 0.01 M Tris-HCl buffer (pH 7.0) for further purification. Kininogenase activity was also found in the pellet dissolved in 0.1% Triton X-100, but was much less than that present in the supernatant. Further purification was done using the supernatant.
Chromatofocusing on Polybuffer Anion Exchanger 94 (PBE94)
The vascular extract was applied to a polybuffer exchanger 94 column (20 X 1 cm) equilibrated with 0.025 M imidazole-hydrochloride buffer (pH 7.4) . A pH gradient between 7.0 and 4.0 was obtained by using polybuffer adjusted to pH 4.0. Proteins that were still bound to the gel after pH 4.0 were eluted with 0.1 M sodium acetate buffer, pH 3.5, 1 M NaCl. During acid elution, the pH was rapidly neutralized by collecting in equal volumes of 2 M Tris-HCl, pH 8.5. The fractions obtained after the sodium acetate elution were pooled in three major fractions of 10 ml each. The fractions were dialyzed against distilled water, concentrated by evaporating under a nitrogen stream at 37°C, and frozen at -70°C until assayed for kininogenase activity.
Affinity Chromatography on Immobilized Kallikrein Antibody
The 7-globulin fraction of the rabbit antiserum against rat kallikrein was purified by precipitation with 40% ammonium sulfate. The kallikrein antibodies of this fraction were further purified by adsorption to, and elution from, a rat glandular kallikrein CH-sepharose column. For this, glandular kallikrein was purified from rat submandibular gland by chromatography on DEAE-Sephadex, adsorption to and elution from a aprotinin-sepharose gel, isoelectric focusing / and gel filtration on high performance liquid chromatography (HPLC) with a TSK-250 column. One microgram of the purified enzyme released 1.1 ng of kinin per minute when incubated with semi-purified dog kininogen (Carretero et al., 1976) . In 12% slab polyacrylamide gel electrophoresis, purified kallikrein (20 /ig) showed a major and a minor band, both of which had kininogenase activity. One milligram of purified rat submandibular gland kallikrein was covalently bound to activated CHsepharose (Pharmacia) as indicated by the manufacturer.
The kallikrein CH-sepharose gel was equilibrated with 0.1 M Tris-HCl, 0.5 M sodium chloride, pH 8.0, and mixed with the antikallikrein antibodies for 2 hours at room temperature and then overnight at 4°C. After the gel was washed to eliminate unbound material, the antikallikrein antibodies were eluted with 0.1 M acetic acid, pH 2.9. Purified kallikrein antibodies were coupled to activated CH-sepharose (Pharmacia), as suggested by the manufacturer. The antikallikrein-sepharose gel was equilibrated with 0.1 M sodium phosphate buffer, pH 7.4. The fraction containing kininogenase after chromatofocusing activity was dissolved in phosphate buffer and mixed with the antikallikrein-sepharose gel for 2 hours at room temperature, followed by 24 hours at 4°C. Nonbound proteins were separated by successive washings first with 0.1 M sodium phosphate buffer (pH 7.4), and then with 0.1 M sodium phosphate buffer (pH 6.0) containing 1 M NaCl. The kininogenase activity was eluted with 0.1 M sodium acetate buffer (pH 3.5) containing 1 M NaCl. Fractions (3 ml) were collected in equal volumes of 2 M Tris, pH 8.5. The samples then were dialyzed against distilled water, concentrated under a nitrogen stream, and frozen at -70°C until assayed for kininogenase activity.
Gel Filtration on Sephadex G-100 and Molecular Weight Determination
Two milliliters of the concentrated solution from the immunoaffinity chromatography step were applied to a Sephadex G-100 column (50 X 1 cm) equilibrated with 0.1 M phosphate buffer, pH 7.4. The column was eluted at a flow rate of 20 ml/hr. Fractions (4 ml) were collected, dialyzed against distilled water, and frozen at -70°C until assayed. Standards used for molecular weight determination were ovalbumin, chymotrypsinogen, and ribonuclease.
Discontinuous Polyacrylamide Gel Electrophoresis
Disc gel electrophoresis was performed in 10% polyacrylamide gels as described by Nustad and Pierce (1974) . Each gel was cut into 2-mm slices, and each slice was homogenized in the presence of 1 ml of 0.1 M sodium phosphate buffer (pH 7.4), centrifuged at 4,000 g for 20 minutes, and the supernatant was saved for kininogenase assay.
High Performance Liquid Chromatography of Kinins
Identification of kinins liberated during kininogenase assay was carried out by comparing the elution volume of kinins generated by the vascular homogenate with that of synthetic bradykinin and lys-bradykinin during reversephase high performance liquid chromatography. Each kinin solution was injected into a Cis Bondapack column equilibrated with 10% acetonitrile in 0.05 M triethyl ammonium formate (TEAF), pH 4.4, and eluted with a linear gradient (10% to 20% acetonitrile in 0.05 M triethyl ammonium formate, TEAF, pH 4.4) with a flow rate of 1 ml/min.
Kininogenase Assay
Kinin-generating activity in tissue extracts and fractions were determined by incubation with partially purified dog kininogen by a method identical to that previously described (Carretero et al., 1976) , except that the buffer was altered by the addition of captopril (10 jig/ml). Kinins were measured by RIA (Carretero et al., 1976) .
Inhibition Studies
The effect of soybean trypsin inhibitor (SBTT) and aprotinin on vascular kininogenase activity was examined. SBTI was dissolved in 0.1 M Tris-HCl (5,000 Mg/ml) and aprotinin was diluted with 0.1 M Tris-HCl (50,000 KIE/ml). The vascular kininogenase was preincubated with 20 jil of the aforementioned inhibitors for 60 minutes at 37°C. The final concentrations of inhibitors was 100 ng of SBTI and 1,000 KIE of aprotinin per ml of sample. The mixture was then incubated with kininogen for assay of kininogenase as described. The 7-globulin fraction of the rabbit antiserum against rat urinary kallikrein was diluted in 0.1 M Tris-HCl buffer (pH 7.4) to a final concentration of 20 mg/ml, and an aliquot containing 10 Mg proteins Each experiment consisted of pooled arteries or veins (100 tng) from three to five rats; n « number of experiments; UKKAb = urinary kallikrein antibodies; SBTI ** soybean trypsin inhibitor (100 Mg/ml); mean values ± SE. Kininogenase activity is expressed per mg protein per hour of incubation. was added to the samples of vascular kininogenase or urinary kallikrein and preincubated for 60 minutes at 37°C. As control, nonimmunized rabbit serum was used in the same concentration. After the preincubation period, the mixture was incubated with kininogen for assay of kininogenase activity. Monoclonal antibodies against rat glandular kallikrein were kindly provided by Dr. R. Savoy-Moore (Savoy-Moore et al. , 1984) . Subclones were propagated by intraperitoneal injection in mice. The ascites fluid containing monoclonal antibodies against kallikrein was used. As a control, we used normal mice serum diluted 1/400 with 0.1 M Tris-HCl, pH 7.4 Protein determination was done by the method of Bradford (1976), using bovine serum albumin as the standard. Protein concentration in column effluents was measured at 280 nm (A^)-Rat urinary kallikrein was purified with a modification of a previously described method . In brief, proteins from rat urine obtained by ammonium sulfate precipitation were chromatographed on a DEAE A52 cellulose column. Fractions containing kininogenase activity were adsorbed to and eluted from a aprotinin-CH-sepharose. Further purification was performed by size exclusion in high performance liquid chromatography using a bio-sil TSK-250 column. Purified rat urinary kallikrein was homogeneous in 12% alkaline polyacrylamide gel electrophoresis and released 1. 60 80 Elutlwi Volumtlml) IOO 94 (20 X 1 cm) equilibrated with 0.025 st imidazole-HCl buffer (pH 7.4). When the pH was 4.0, the vascular kininogenase  and urinary kallikrein were eluted with 0.1 M sodium acetate buffer,  1 M NaCl (pH 3.5). Fractions of 2 ml were collected over 2 ml of 2 M  Tris-HCl, pH 8.5 
FIGURE 1. Chromatofocusing on polybuffer anion exchanger 94 (PBE 94). Vascular kininogenase and urinary kallikrein were applied to a column of PBE
. Open circles and triangles indicates inhibition of the kininogenase activity by incubation with kallikrein antibodies.
Mg protein per min when incubated with semipurified dog kininogen.
Rat plasma kallikrein was prepared from blood collected into 1/10 volumes of 0.1 M sodium citrate solution and centrifuged at 1500 g for 30 minutes at 4°C. Acetone was added to the plasma (17% vol/vol) for 18 hours at room temperature. The acetone was evaporated under a nitrogen stream. After correction for water loss, the preparation was kept at -20°C until needed. Table 1 shows the kininogenase activity of several preparations of tail arteries and veins. The mean values of kininogenase activity and the inhibition profile with kallikrein antibodies and soybean-trypsin inhibitor were similar for both types of blood vessel.
Results
The results of the partial purification of rat vascular kininogenase are summarized in Table 2 . Chromatofocusing resulted in a 2-fold increase in the specific activity, but total activity also increased after this step. With immunoaffinity, the specific activity increased up to 68-fold. After gel filtration, a 78-fold purification with 95% recovery was obtained. On chromatofocusing, vascular kininogenase and purified rat urinary kallikrein eluted together when pH reached 3.5 (Fig. 1) . This indicates that their isoelectric point is below 4.0. 2. Affinity chromatography of vascular extract on antikallikrein-CH-sepharose. The gel was equilibrated with 0.1 M sodium  phosphate buffer (pH 7.4). Weakly bound proteins were eluted with  0.1 M sodium phosphate, 1 u NaCl (pH 6.0), and the vascular  kininogenase was eluted with 0.1 u sodium acetate buffer, 1 MNaCl  (pH 3.5 On immunoaffinity chromatography, the kininogenase activity was eluted in a single peak with 0.1 M sodium acetate buffer (pH 3.5), 1 M NaCl (Fig.  2) . Vascular and urinary kininogenases also eluted in a single peak on gel filtration (Fig. 3) . Kininogenase activity of both vascular and urinary kallikrein was inhibited by incubation with kallikrein antibodies. The apparent molecular weight of vascular kininogenase as calculated from the elution volume on the gel filtration column was 37,000 daltons (Fig. 4) .
). Open circles indicate inhibition of the kininogenase activity by incubation with kallikrein antibodies.
Mobility on disc polyacrylamide gel electrophoresis of both vascular kininogenase and urinary kallikrein was similar (Fig. 5) .
The kininogenase activity of both vascular kininogenase and urinary kallikrein was completely inhibited (98 ± 2%) by aprotinin (not shown in the figure), whereas it was resistant to soybean trypsin inhibitor. In contrast, the kininogenase activity of trypsin and plasma was strongly inhibited by soybean trypsin inhibitor (Fig. 6 ). Kininogenase activity of both enzymes was inhibited to the same extent by kallikrein antibodies. Nonimmunized rabbit serum had a negligible effect. Identification of the reaction products by reverse phase HPLC showed that kinins generated by vascular kininogenase had the same elution volume as synthetic bradykinin (Fig. 7) . kininogenase, urinary kallikrein, trypsin, and rat plasma (plasma kallikrein) . The different enzyme preparations were incubated for 60 minutes at 37°Q pH 8.5, with kallikrein antibody, nonimmunized tabbit serum, or soybean trypsin inhibitor, then kininogenase activity was measured. The values represent the mean of at least three determinations. 
FIGURE 7. Elution of synthetic kinin standards or kinin generated by the vascular extract. The column was equilibrated and eluted at a flow rate of 1.0 ml/min, as described in Methods. Kinin content of the fractions was measured by R1A Upper injection of a mixture of synthetic bradykinin (Bk) or Lys-bradykinin (LYS-Bk). Lower injection of the kinin product of the vascular kininogenase.
Discussion
The present study demonstrates that a kininforming enzyme is present in rat vascular tissue. Vascular kininogenase was purified by a series of chromatographic steps with a very high yield. This was unexpected, since the combination of these chromatographic steps usually results in much lower recoveries (Fiedler, 1979) . Whereas we do not have an explanation for this high yield, it is possible that either activation of a proenzyme or separation from inhibitors may have occurred during purification. Chromatofocusing is likely to be an 'activating' step, since it yielded 125% of the loaded activity. The insensitivity of the vascular kininogenase to SBTI readily distinguishes it from trypsin and plasma kallikrein. On the other hand, rat vascular kininogenase appears to be very similar to rat glandular kallikrein; both purified rat vascular kininogenase and urinary kallikrein had similar molecular weights, isoelectric points, electrophoretic mobilities, and inhibition profiles. Only bradykinin was released by vascular kallikrein. This is not surprising, since rat glandular kallikrein differ from similar enzymes from other species in that they generate bradykinin and not lys-bradykinin (Seki et al., 1972; Alhenc-gelas et al., 1981; Yamada and Erdos, 1982) .
The similar behavior of both enzymes when reacted with rabbit antiserum against rat urinary kallikrein strengthens the contention that they are very similar if not identical. Vascular kininogenase and urinary kallikrein were strongly bound to kallikrein antiserum coupled to CH-sepharose, since they were not released when the gel was washed with buffer, pH 6.0, containing 1 M NaCl. The property of the Circulation Research/Vol. 56, No. 6, June 1985 vascular kininogenase to bind strongly to immobilized kallikrein antiserum was used for its partial purification from vascular tissue. The combination of chromatofocusing, gel filtration, and immunoaffmity chromatography resulted in a 70-fold purification. Due to the small amount of material available, the analytical techniques usually used to determine purity were not performed.
We do not know at this time the precise localization of vascular kininogenase within the vascular structures. Recently, it has been reported that mast cells from humans and rats have a kallikrein-like enzyme (Proud et al., 1982; Garret et al., 1984) , and it has been clearly demonstrated that these cells are normally present around the arterioles, capillaries, venules, and beneath the endothelium in man and rats (McGovern, 1956; Robinson et al., 1978; Plonsky and Boyles, 1981) .
In our experiments, the presence of mast cells cannot be ruled out, but recent studies have demonstrated that the kininogenase present in human mast cells is not immunologically cross-reactive with glandular kallikrein (Proud et al., 1982) . In addition, the one present in rat mast cells is not inhibited by aprotinin (Garret et al., 1982; Garret et al., 1984) . These two important differences should be taken into consideration when comparing them with the vascular kininogenase described here.
Although the precise cellular localization of vascular kininogenase is still unknown, it could be speculated that the enzyme may play a role in regulating local vascular resistance and, hence, blood flow, either directly or through kinin release. If the enzyme is located in the endothelial lining, it may participate in the regulation of phospholipase activity and local formation of arachidonic acid metabolites, either directly (Morita et al., 1984) , or through kinin formation (Whorton et al., 1982) . If the enzyme is located in smooth muscle, it may participate directly in regulation of vascular tone, and, if located in the adventitia, could have a role in regulating vascular permeability. Furthermore, a recent report (Cardin et al., 1984) suggests that low density lipoproteins are a substrate for tissue kallikrein; thus, tissue kallikrein may participate in low density lipoprotein metabolism within the vascular wall.
In summary, a protease(s) which resembles glandular kallikrein is present in vessels isolated from rat tails. This enzyme is present in an active form, and its isoelectric point, molecular weight, and immunological characteristics are similar to those of urinary kallikrein.
